Ruohan Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ruohan Li has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Changqing Yang
Department of Respiratory and Critical Care Medicine, Tianjin Medical University General Hospital, No. 154 Anshan Street, Heping District, Tianjin, 300052, China
1 shared publication - Di Wu
Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education) of the Second Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou 310029, China
1 shared publication Huixin Zhang
Tianjin Medical University, No. 22 Qixiangtai Road, Heping District, Tianjin, 300070, China
1 shared publicationJau-Shyong Hong
Neurobiology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, NC, 27709, USA
1 shared publicationJunjie Xie
Department of Respiratory and Critical Care Medicine, Tianjin Medical University General Hospital, No. 154 Anshan Street, Heping District, Tianjin, 300052, China
1 shared publicationLeilei Shi
Department of Respiratory and Critical Care Medicine, Tianjin Medical University General Hospital, No. 154 Anshan Street, Heping District, Tianjin, 300052, China
1 shared publication
Latest Publications
- 24 September 2026
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1035, 179372
Targeting the Snail1–ATGL–ferroptosis–EMT axis via AKT–GSK3β signaling: Low-dose colchicine attenuates idiopathic pulmonary fibrosis
- 24 September 2026
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1035, 179372
Targeting the Snail1–ATGL–ferroptosis–EMT axis via AKT–GSK3β signaling: Low-dose colchicine attenuates idiopathic pulmonary fibrosis
- 29 February 2024
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 392, 110926
Icaritin activates p53 and inhibits aerobic glycolysis in liver cancer cells
- 29 February 2024
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 392, 110926
Icaritin activates p53 and inhibits aerobic glycolysis in liver cancer cells